162 related articles for article (PubMed ID: 34692992)
21. Fibroid management in premenopausal women.
Donnez J; Courtoy GE; Dolmans MM
Climacteric; 2019 Feb; 22(1):27-33. PubMed ID: 30601065
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic management of uterine fibroid tumors: updated French guidelines.
Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic management of uterine fibroid tumors.
Puchar A; Feyeux C; Luton D; Koskas M
Minerva Ginecol; 2016 Aug; 68(4):466-76. PubMed ID: 26698838
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis.
Fuldeore MJ; Soliman AM
Int J Womens Health; 2017; 9():403-411. PubMed ID: 28652819
[TBL] [Abstract][Full Text] [Related]
25. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
[TBL] [Abstract][Full Text] [Related]
26. Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.
AbdElmagied AM; Vaughan LE; Weaver AL; Laughlin-Tommaso SK; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Gorny KR; Leppert PC; Lemens MA; Stewart EA
Am J Obstet Gynecol; 2016 Sep; 215(3):338.e1-338.e18. PubMed ID: 27073063
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-guided radiofrequency ablation of symptomatic uterine fibroids: short-term evaluation of effect of treatment on quality of life and symptom severity.
Iversen H; Lenz S; Dueholm M
Ultrasound Obstet Gynecol; 2012 Oct; 40(4):445-51. PubMed ID: 22378629
[TBL] [Abstract][Full Text] [Related]
28. Loss of stiffness in collagen-rich uterine fibroids after digestion with purified collagenase Clostridium histolyticum.
Jayes FL; Liu B; Moutos FT; Kuchibhatla M; Guilak F; Leppert PC
Am J Obstet Gynecol; 2016 Nov; 215(5):596.e1-596.e8. PubMed ID: 27177523
[TBL] [Abstract][Full Text] [Related]
29. Alternatives to hysterectomy: The burden of fibroids and the quality of life.
Fortin C; Flyckt R; Falcone T
Best Pract Res Clin Obstet Gynaecol; 2018 Jan; 46():31-42. PubMed ID: 29157931
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic Fibroid Management: Systematic Review of the Literature.
Havryliuk Y; Setton R; Carlow JJ; Shaktman BD
JSLS; 2017; 21(3):. PubMed ID: 28951653
[TBL] [Abstract][Full Text] [Related]
31. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
32. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
33. Treatment Choices in a National Cohort of Canadian Women With Symptomatic Uterine Fibroids.
Strand T; Kives S; Leyland N; Ashkenas J; Janiszewski P; Thiel J
J Obstet Gynaecol Can; 2020 Dec; 42(12):1475-1482.e2. PubMed ID: 33046429
[TBL] [Abstract][Full Text] [Related]
34. Uterine artery embolization versus surgical treatment in patients with symptomatic uterine fibroids: Protocol for a systematic review and meta-analysis of individual participant data.
Middelkoop MA; Harmsen MJ; Manyonda I; Mara M; Ruuskanen A; Daniels J; Mol BWJ; Moss J; Hehenkamp WJK; Wu O
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():179-183. PubMed ID: 33246202
[TBL] [Abstract][Full Text] [Related]
35. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of the psychosocial impact of fibroids before and after treatment.
Go VAA; Thomas MC; Singh B; Prenatt S; Sims H; Blanck JF; Segars JH
Am J Obstet Gynecol; 2020 Nov; 223(5):674-708.e8. PubMed ID: 32474012
[TBL] [Abstract][Full Text] [Related]
37. Uterine fibroids: Correlations of anemia and pain to fibroid location and uterine weight.
Bachmann GA; Bahouth LA; Amalraj P; Mhamunkar V; Hoes K; Ananth CV
J Reprod Med; 2011; 56(11-12):463-6. PubMed ID: 22195327
[TBL] [Abstract][Full Text] [Related]
38. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
[TBL] [Abstract][Full Text] [Related]
39. Fibroids treated with uterine artery embolization: do imaging findings correlate with patient outcomes?
Millo N; Boroditsky R; Lyons EA
J Obstet Gynaecol Can; 2010 May; 32(5):460-466. PubMed ID: 20500955
[TBL] [Abstract][Full Text] [Related]
40. Discussing sarcoma risks during informed consent for nonhysterectomy management of fibroids: an unmet need.
Seagle BL; Alexander AL; Strohl AE; Shahabi S
Am J Obstet Gynecol; 2018 Jan; 218(1):103.e1-103.e5. PubMed ID: 28951264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
